Unlock stock picks and a broker-level newsfeed that powers Wall Street.
NYSE - Delayed Quote USD

Doximity, Inc. (DOCS)

Compare
58.51
-2.04
(-3.37%)
At close: March 28 at 4:00:02 PM EDT
58.03
-0.48
(-0.82%)
After hours: March 28 at 7:32:15 PM EDT
Loading Chart for DOCS
  • Previous Close 60.55
  • Open 60.01
  • Bid 57.52 x 900
  • Ask 58.50 x 800
  • Day's Range 57.72 - 60.25
  • 52 Week Range 22.96 - 85.21
  • Volume 1,950,346
  • Avg. Volume 2,448,440
  • Market Cap (intraday) 10.979B
  • Beta (5Y Monthly) 1.35
  • PE Ratio (TTM) 58.51
  • EPS (TTM) 1.00
  • Earnings Date May 14, 2025 - May 19, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 74.94

Doximity, Inc. operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with digital tools built for medicine, that enables its members to collaborate with colleagues, stay up to date with the latest medical news and research, manage their careers and on-call schedules, streamline documentation and administrative paperwork, and conduct virtual patient visits. It primarily serves physicians, nurse practitioners, physician assistants, medical students, pharmaceutical manufacturers, and healthcare systems. The company was formerly known as 3MD Communications, Inc. and changed its name to Doximity, Inc. in June 2010. Doximity, Inc. was incorporated in 2010 and is headquartered in San Francisco, California.

www.doximity.com

827

Full Time Employees

March 31

Fiscal Year Ends

Recent News: DOCS

View More

Performance Overview: DOCS

Trailing total returns as of 3/28/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

DOCS
9.59%
S&P 500 (^GSPC)
5.11%

1-Year Return

DOCS
117.43%
S&P 500 (^GSPC)
6.22%

3-Year Return

DOCS
19.41%
S&P 500 (^GSPC)
21.97%

5-Year Return

DOCS
42.12%
S&P 500 (^GSPC)
119.59%

Compare To: DOCS

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: DOCS

View More

Valuation Measures

Annual
As of 3/28/2025
  • Market Cap

    10.98B

  • Enterprise Value

    10.15B

  • Trailing P/E

    58.51

  • Forward P/E

    39.53

  • PEG Ratio (5yr expected)

    3.16

  • Price/Sales (ttm)

    21.35

  • Price/Book (mrq)

    10.65

  • Enterprise Value/Revenue

    18.44

  • Enterprise Value/EBITDA

    43.43

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    36.60%

  • Return on Assets (ttm)

    12.88%

  • Return on Equity (ttm)

    21.24%

  • Revenue (ttm)

    550.17M

  • Net Income Avi to Common (ttm)

    201.34M

  • Diluted EPS (ttm)

    1.00

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    844.94M

  • Total Debt/Equity (mrq)

    1.26%

  • Levered Free Cash Flow (ttm)

    189.25M

Research Analysis: DOCS

View More

Company Insights: DOCS

Research Reports: DOCS

View More

People Also Watch